Cisplatin-Rubusoside Nanomicelles Improves Anti-Cancer Activity of Cisplatin against Multi-Drug-Resistant Breast Cancer Cells by Upregulating p21

Rahul Gaikwad; Pooja Kadu; Avadhut Kale; Dinesh Deshmukh; Vidya Bakan; Rohini Dhakarge

doi:10.52711/0974-360X.2026.00304

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Cisplatin-Rubusoside Nanomicelles Improves Anti-Cancer Activity of Cisplatin against Multi-Drug-Resistant Breast Cancer Cells by Upregulating p21

Author(s): Rahul Gaikwad, Pooja Kadu, Avadhut Kale, Dinesh Deshmukh, Vidya Bakan, Rohini Dhakarge

Email(s): rahul.gaikwad1167@gmail.com

DOI: 10.52711/0974-360X.2026.00304

Address: Rahul Gaikwad1*, Pooja Kadu1, Avadhut Kale1, Dinesh Deshmukh2, Vidya Bakan3, Rohini Dhakarge1
1Department of Pharmaceutics, Dnyansadhana College of Pharmacy, Parbhani, MH-431505.
2Department of Pharmaceutics, Deshmukh Institute of Pharmacy Balsond, Hingoli, MH- 431513.
3Departments of Pharmacology, Durgamata Institute of pharmacy, Parbhani, MH-431505.
*Corresponding Author

Published In: Volume - 19, Issue - 5, Year - 2026

Keywords:

Cite this article:
Rahul Gaikwad, Pooja Kadu, Avadhut Kale, Dinesh Deshmukh, Vidya Bakan, Rohini Dhakarge. Cisplatin-Rubusoside Nanomicelles Improves Anti-Cancer Activity of Cisplatin against Multi-Drug-Resistant Breast Cancer Cells by Upregulating p21. Research Journal Pharmacy and Technology. 2026;19(5):2117-0. doi: 10.52711/0974-360X.2026.00304

Purchase PDF